In total, COVID resulted in reduced spending of approximately $325 million, driven largely by lower promotional, selling, and administrative costs, along with lower laboratory travel and meeting expenses.

Jul 31, 2020 / CFO / receipt, needs a key / Rob (CFO), CFO | earnings call 2020-07-31 | transcript b0b5e2c6-4be0-4f3e-90c2-5035f3bb4669 | chars 13876-14080 | segment 13